Evidence map›Paper›PMID 31109070›Full record

ArticleJournal of clinical medicine2019

Systemic Inflammation in Metabolic Syndrome: Increased Platelet and Leukocyte Activation, and Key Role of CX

Patrice Marques, Aida Collado, Sergio Martinez-Hervás, Elena Domingo, Esther Benito, Laura Piqueras, José T Real, Juan F Ascaso, Maria-Jesus Sanz

Open access · goldAbstract read
In one paragraph

Article in Journal of clinical medicine, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed
2.2field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 44 citations in OpenAlex.

  1. Review
  2. Review
  3. Beyond CYP2C19: inflammation and angiogenesis gene variants drive clopidogrel resistance in CAD patients.Inflammation research : official journal of the European Histamine Research Society ... [et al.] · 2025
    Article
  4. Review
  5. Article
  6. Review
  7. Article
  8. Article
  9. Review
  10. Article
  11. Review
  12. CRP/HDL-C and Monocyte/HDL-C ratios as Predictors of Metabolic Syndrome in Patients With Type 2 Diabetes Mellitus.Acta informatica medica : AIM : journal of the Society for Medical Informatics of Bosnia & Herzegovina : casopis Drustva za medicinsku informatiku BiH · 2023
    Article
  13. Article
  14. Article
  15. Review
  16. Review
  17. Article
  18. Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Patrice MarquesDepartment of Pharmacology, University of Valencia, Av. Blasco Ibáñez 15, 46010 Valencia, Spain. patricegmarques@gmail.com.ORCID 0000-0003-0465-1727
Aida ColladoDepartment of Pharmacology, University of Valencia, Av. Blasco Ibáñez 15, 46010 Valencia, Spain. aida.collado@uv.es.ORCID 0000-0002-3183-2104
Sergio Martinez-HervásInstitute of Health Research INCLIVA, Av. Menéndez Pelayo 4, 46010 Valencia, Spain. Sergio.Martinez@uv.es.ORCID 0000-0002-6775-2034
Elena DomingoDepartment of Pharmacology, University of Valencia, Av. Blasco Ibáñez 15, 46010 Valencia, Spain. eledo2@hotmail.com.
Esther BenitoInstitute of Health Research INCLIVA, Av. Menéndez Pelayo 4, 46010 Valencia, Spain. esther.benito@hotmail.com.ORCID 0000-0003-3445-2913
Laura PiquerasDepartment of Pharmacology, University of Valencia, Av. Blasco Ibáñez 15, 46010 Valencia, Spain. laura.piqueras@uv.es.
José T RealInstitute of Health Research INCLIVA, Av. Menéndez Pelayo 4, 46010 Valencia, Spain. Jose.T.Real@uv.es.
Juan F AscasoInstitute of Health Research INCLIVA, Av. Menéndez Pelayo 4, 46010 Valencia, Spain. ascaso@uv.es.
Maria-Jesus SanzDepartment of Pharmacology, University of Valencia, Av. Blasco Ibáñez 15, 46010 Valencia, Spain. maria.j.sanz@uv.es.ORCID 0000-0002-8885-294X
Universitat de València · ESInstituto de Salud Carlos III · ES

Funding

Carlos III Health Institute and the European Regional Development Fund PI15/00082Carlos III Health Institute and the European Regional Development Fund PI18/00209Carlos III Health Institute and the European Regional Development Fund PIE15/00013Spanish Ministry of Economy and Competiveness and the European Regional Development Fund SAF2014-57845-RSpanish Ministry of Economy and Competiveness and the European Regional Development Fund SAF2017-89714-R
6 · The paper itself

Abstract

backgroundMetabolic syndrome is associated with low-grade systemic inflammation, which is a key driver of premature atherosclerosis. We characterized immune cell behavior in metabolic syndrome, its consequences, and the potential involvement of the CX

methodsWhole blood from 18 patients with metabolic syndrome and 21 age-matched controls was analyzed by flow cytometry to determine the leukocyte immunophenotypes, activation, platelet-leukocyte aggregates, and CX

resultsWhen compared with the controls, the metabolic syndrome patients presented greater percentages of eosinophils, CD3

conclusionWe provide evidence of generalized immune activation in metabolic syndrome. Additionally, CX

Indexed as

chemokinescytokinesendothelial dysfunctionleukocyte activationmetabolic syndromeplatelet activationsystemic inflammation

Identifiers

PMID31109070
PMCPMC6572270
OpenAlexW2945823458

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.